Molecular Partners and Orano Med Team Up for Alpha Radiotherapies for Cancer (MOLN: NASDAQ)


cancer patient and modern treatment

Xesai

  • Biotechnology company in clinical phase Molecular Partners (NASDAQ:CLOUD) and Orano Med, a radiopharmaceutical company in the clinical phase expand their strategic collaboration.
  • The terms of the new agreement include the development of six additional targeted alpha therapeutic candidates, now representing a total of ten potential candidates.



Source link

  • Related Posts

    Inflation in France slowed to 0.4% in January

    Inflation in France slowed to 0.4% in January Source link

    Lock in up to 4.05% APY today

    Deposit account fees are on the decline, but the good news is that you can get a competitive return on one certificate of deposit (CD) today and preserve your earning…

    Leave a Reply

    Your email address will not be published. Required fields are marked *